Foundation Venture Capital Group, LLC
Impact investorPrinceton · Pre-Seed–Seed · 5 people tracked
Find your way into Foundation Venture Capital Group, LLC
Sign up to see every warm intro you have to Foundation Venture Capital Group, LLC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Foundation Venture Capital Group, LLC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Foundation Venture Capital Group practices impact investing focused on New Jersey's health-related technology sector. It provides pre-seed and seed capital to early-stage startups emerging from affiliated research organizations, aiming to generate measurable social impact while advancing innovations toward commercialization. Beyond capital, it offers nonmonetary support including strategic, operational, and back-office assistance beginning before incorporation and continuing through the company's life cycle until traditional venture funding becomes viable. Gains from investments are reinvested to fund further research and innovation at affiliated organizations. The firm also helps portfolio companies connect with traditional venture capital partners to further commercialize their discoveries for patient benefit.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & public directoriesWhat they invest in
from 7 of 14 portfolio companiesBiotech ×7Healthtech ×5Digital Health ×2Medical Devices ×2AI & Machine Learning ×1Mental Health ×1New Materials ×1
HQs:United States×5
Investments · 14 tracked
founders shown can be your intro pathBy year:2023 · 12019 · 23 dated
NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries.
BiotechHealthtechMedical DevicesMonmouth Junction, US
Charles J. Gatt, Jr., MD(Founder & CEO)Michael G. Dunn, PhD(Founder & Secretary/Treasurer)Kevin Weadock, PhD(Chief Operating Officer)
Zena Therapeutics is a therapeutics company developing drug candidates, with work spanning molecular design, pharmacology, animal studies, and clinical trial design toward IND submission.
BiotechHealthtechMental HealthPrinceton, US
Eileen Carry, PhD(Founder)inEileen Carry(Chief Scientific Officer | co-Founder)Ariane Vasilatis(Chief Executive Officer | co-Founder)
Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease.
AI & Machine LearningBiotechDigital HealthStratford, US
Mert Sahin(Executive Officer)Benjamin A. Belinka, Jr.(Executive Officer)
BoardRobert Nagele(Director)Rene Chaze(Director)
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Mark Esposito(CSO, Co-Founder and Board Member)inYibin Kang(Chair, Scientific Advisory Board and Co-Founder)Kendall Mohler(Executive Officer, Director)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)in
Co-investors7G BioVenturesBioAdvance
Focused on longevity technologies; Foundation sold its equity interest to Rostock International, Ltd.
Co-investorsXploration Capital
NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.
BiotechDigital HealthHealthtechMedical Devices
Mark(Associate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School)Martin(Chief Executive Officer)
Mattek develops human-relevant in vitro research products, including lab-grown 3D human epithelial tissue models, banks of primary human cells, and cell culture dishes and plates optimized for cell growth and imaging.
BiotechHealthtechNew Materials
Michael Johnson(Cofounder)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ActinobacActinobac BiomedEValuate Diagnostics, Inc.KairosventuresMentiNovaUpstream Access, Inc.Zena Therapeutic
Exits · 1
1 acquisitionsVisikolacq. by MatTek (BICO Group)
Frequently asked questions
- How many investments has Foundation Venture Capital Group, LLC made?
- Foundation Venture Capital Group, LLC has 14 tracked investments, 1 of which have exited.
- What stage does Foundation Venture Capital Group, LLC invest at?
- Foundation Venture Capital Group, LLC invests at the Pre-Seed, Seed stages.
- What is Foundation Venture Capital Group, LLC's typical check size?
- Foundation Venture Capital Group, LLC typically writes checks of $500K.
- What sectors does Foundation Venture Capital Group, LLC focus on?
- Foundation Venture Capital Group, LLC focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices, Mental Health.
- Where is Foundation Venture Capital Group, LLC located?
- Foundation Venture Capital Group, LLC is headquartered in Princeton, US.
Similar investors
Serendipity Impact VC is an early-stage venture firm backing founders building breakthrough technologies focused exclusively on mental and neuro health.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
The Catalytic Impact Foundation is a philanthropic organization that invests donor capital into early-stage life sciences and healthcare companies addressing unmet medical needs. It applies venture capital discipline to deploy catalytic philanthropic funding that helps bridge the gap between research grants and for-profit investment.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
Relentless Venture Fund is a venture capital firm investing in companies focused on health, activity and longevity, drawing on technical, operational, venture, healthcare, high performance and social impact finance expertise.


















